Timing of thoracic irradiation in limited stage small-cell lung cancer: is it still a star on the rise?
Bibliographic record
Abstract
Early cisplatin-based concurrent chemoradiotherapy (CRT) is a mainstay treatment in limited stage small-cell lung cancer (LS SCLC; the Union for International Cancer Control stage I-III). This is based on the several randomized trials and meta-analyses. Most considerable of them are the National Cancer Institute of Canada (NCIC), Intergroup-0096, and the Japan Clinical Oncology Group (JCOG)-9104 trials [1-3]. These studies included pre-chemotherapy extent of the tumor in radiation portals and demonstrated 5-year survival rates over 20%. Importantly, starting point and application of thoracic irradiation (TRT) in these trials was different. In NCIC study mild hypofractionated TRT was applied with the second cycle whereas in the INT-0096 and JCOG-9104 (concurrent arm) trials accelerated hyperfractionated radiotherapy was started with the first cycle of chemotherapy. In all these trials TRT began within 30 days after initiation of chemotherapy, treatment time of TRT was less than 30 days and dose delivery of chemotherapy and TRT was more than 80%. Another substantial aspect was that deferred application of TRT in the late arms of NCIC and JCOG-9104 trials resulted in the increase of CRT duration as a whole treatment. A retrospective study has reported that in LS SCLC duration of CRT, itself, can also affect overall survival. Recently published randomized phase III trial of Sun et al. [4] demonstrated that outcome achieved with TRT starting with the third cycle of chemotherapy is non-inferior to results when radiotherapy was administered from the first day of systemic treatment. Median survival, remission rates and estimated 5-year survival rates were equal in early and late arms and comparable with best historical results. Although total radiation dose was lower than actual standard, dose-delivery of chemotherapy and TRT was high. In the late TRT arm initially involved lymph nodes were considered in the target definition even a significant response occurred after the second chemotherapy cycle. How can we declare the results of this study? Most relevant finding of Sun et al. [4] is, probably, the fact that in both arms complete responders to CRT demonstrated significant better outcome compared to partial and non-responders. Complete response remains to be highly significant variable correlating with overall survival on the multivariate analysis. This strong correlation is very important and was not reported in the earlier randomized trials. Solely, study of Jeremic et al. [5] found higher complete remission rate in the early TRT arm accompanied with better long-term results, but remission grade of the tumor, itself, was not analysed as a prognostic factor. There is a growing body of evidence to keep response of the tumor in course of CRT under control. Small studies have already demonstrated that rapid achievement of complete remission in LS SCLC can be a significant prognostic factor.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.002 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".